Latest Trials Latest NewsFAQ

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Prevention of PTSD III: Neurocognitive Training of Emotional Regulation

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder
Major Depression
Anxiety Disorders

Interventions: Procedure: Neurocognitive retraining Web Based Intervention
Other: Control, web-based tasks

First Posted Date: 2014-03-13

Last Posted Date: 2018-08-31

Lead Sponsor: NYU Langone Health

Target Recruit Count: 180

Registration Number: NCT02085512

Locations: 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel

A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

Phase 3

Withdrawn

Conditions: Hepatic Encephalopathy

Interventions: Drug: Rifaximin
Drug: Lactulose

First Posted Date: 2014-03-13

Last Posted Date: 2016-03-02

Lead Sponsor: NYU Langone Health

Registration Number: NCT02086825

Locations: 🇺🇸
New York University Langone Medical Center, New York, New York, United States

Symptom Management for Irritable Bowel Syndrome

Not Applicable

Completed

Conditions: Irritable Bowel Syndrome

Interventions: Other: Individualized protocol
Other: Sham acupuncture/Placebo moxa
Other: Standard protocol

First Posted Date: 2014-03-06

Last Posted Date: 2020-07-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 183

Registration Number: NCT02079857

Locations: 🇺🇸
NYU Division of Special Studies in Symptom Management, New York, New York, United States

Phase I/II Trial of the Combination of Lenalidomide (Revlimid) and Nab-paclitaxel (Abraxane) in the Treatment of Relapsed/Refractory Multiple Myeloma

Phase 1

Terminated

Conditions: Relapsed or Refractory Multiple Myeloma

Interventions: Drug: Lenalidomide
Drug: nab-paclitaxel

First Posted Date: 2014-03-03

Last Posted Date: 2018-10-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 3

Registration Number: NCT02075021

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

Aortic Valve and Root Measurements Under Real-Time 3-Dimensional Visualization During Angiography

Not Applicable

Completed

Conditions: Coronary Artery Disease
Aortic Stenosis

Interventions: Radiation: Real-time 3-dimensional DynaCT

First Posted Date: 2014-02-27

Last Posted Date: 2017-07-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 25

Registration Number: NCT02073617

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

World Trade Center Adolescent Health Study

Completed

Conditions: Exposure to Toxic Dust
Asthma
Hypertension
Cardiovascular Risk Factor
Insulin Resistance
Stress Disorders, Post-Traumatic

First Posted Date: 2014-02-21

Last Posted Date: 2017-01-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 402

Registration Number: NCT02068183

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

Poly ICLC, Radiation, and Romidepsin for Advanced Cutaneous T Cell Lymphoma

Phase 1

Terminated

Conditions: Cutaneous T-cell Lymphoma

Interventions: Drug: Romidepsin
Drug: Poly ICLC
Radiation: Focal lesional radiation

First Posted Date: 2014-02-12

Last Posted Date: 2018-12-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 3

Registration Number: NCT02061449

Locations: 🇺🇸
NYU Cancer Institute, New York, New York, United States

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence

Phase 2

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Diphenhydramine
Drug: Psilocybin
Behavioral: Motivational Enhancement and Taking Action (META)

First Posted Date: 2014-02-12

Last Posted Date: 2022-11-08

Lead Sponsor: NYU Langone Health

Target Recruit Count: 95

Registration Number: NCT02061293

Locations: 🇺🇸
Clinical and Translational Science Institute, NYU Langone Medical Center, New York, New York, United States
🇺🇸
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

Functional Brain Imaging in PTSD

Completed

Conditions: Post-traumatic Stress Disorder (PTSD)
Trauma

Interventions: Procedure: Positron emission tomography/magnetic resonance imaging

First Posted Date: 2014-02-03

Last Posted Date: 2016-03-03

Lead Sponsor: NYU Langone Health

Target Recruit Count: 50

Registration Number: NCT02053532

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer

Not Applicable

Terminated

Conditions: Prostate Cancer

Interventions: Device: PET/CT
Device: PET/MRI

First Posted Date: 2014-01-22

Last Posted Date: 2017-07-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 10

Registration Number: NCT02042053

Locations: 🇺🇸
New York University Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy